$LYRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Lyra Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Lyra Therapeutics, Inc.. Get notifications about new insider transactions in Lyra Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2020 | LYRA | Lyra Therapeutics, ... | snyderman nancy lynn MD | Director | Buy | P | 9.72 | 1,025 | 9,963 | 1,025 | 0 to 1 K |
Aug 05 2020 | LYRA | Lyra Therapeutics, ... | Nelson Pamela E. | Senior VP, Regulato ... | Option Exercise | A | 13.68 | 35,000 | 478,800 | 35,000 | |
Jun 26 2020 | LYRA | Lyra Therapeutics, ... | Richard Robert E. | SVP of R&D | Option Exercise | A | 12.33 | 35,000 | 431,550 | 35,000 | |
May 29 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 1,934,115 | 1.3 M to 1.9 M (+47.74 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Option Exercise | X | 8.63 | 31,382 | 270,827 | 0 | |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Option Exercise | C | 0.00 | 3,607,224 | 0 | 0 | |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Option Exercise | C | 0.00 | 11,666,666 | 0 | 0 | |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | P | 16.00 | 155,000 | 2,480,000 | 155,000 | 0 to 155 K |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Sell | S | 16.00 | 16,909 | 270,544 | 457,421 | 474.3 K to 457.4 K (-3.56 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | X | 8.63 | 31,382 | 270,827 | 474,330 | 442.9 K to 474.3 K (+7.08 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | C | 0.00 | 104,608 | 0 | 442,948 | 338.3 K to 442.9 K (+30.92 %) |
May 15 2020 | LYRA | Lyra Therapeutics, ... | Soleus Private Equity GP I, LL ... | 10% Owner | Buy | C | 0.00 | 338,330 | 0 | 338,330 | 0 to 338.3 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | X | 8.63 | 13,449 | 116,065 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | X | 8.63 | 10,322 | 89,079 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | X | 8.63 | 21,060 | 181,748 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,545,953 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,186,496 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,420,729 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,995,489 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,531,507 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,124,633 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,391,895 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,835,743 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,745,346 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,929,790 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,248,569 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 4,587,608 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,088,772 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,603,102 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,270,702 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,948,948 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,495,786 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,051,758 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,647,727 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 541,973 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,105,754 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,725,090 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 567,420 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,157,670 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | P | 16.00 | 75,000 | 1,200,000 | 553,123 | 478.1 K to 553.1 K (+15.69 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | P | 16.00 | 57,561 | 920,976 | 381,618 | 324.1 K to 381.6 K (+17.76 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | P | 16.00 | 117,439 | 1,879,024 | 778,592 | 661.2 K to 778.6 K (+17.76 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Sell | S | 16.00 | 7,255 | 116,080 | 478,123 | 485.4 K to 478.1 K (-1.49 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | X | 8.63 | 13,449 | 116,065 | 485,378 | 471.9 K to 485.4 K (+2.85 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Sell | S | 16.00 | 5,568 | 89,088 | 324,057 | 329.6 K to 324.1 K (-1.69 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | X | 8.63 | 10,322 | 89,079 | 329,625 | 319.3 K to 329.6 K (+3.23 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Sell | S | 16.00 | 11,360 | 181,760 | 661,153 | 672.5 K to 661.2 K (-1.69 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | X | 8.63 | 21,060 | 181,748 | 672,513 | 651.5 K to 672.5 K (+3.23 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | C | 0.00 | 471,929 | 0 | 471,929 | 0 to 471.9 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | C | 0.00 | 319,303 | 0 | 319,303 | 0 to 319.3 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | NBVM GP, LLC | 10% Owner | Buy | C | 0.00 | 651,453 | 0 | 651,453 | 0 to 651.5 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | WHITESIDES GEORGE M | Director | Option Exercise | C | 0.00 | 67,672 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | WHITESIDES GEORGE M | Director | Option Exercise | C | 0.00 | 55,991 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | WHITESIDES GEORGE M | Director | Option Exercise | C | 0.00 | 97,216 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | WHITESIDES GEORGE M | Director | Buy | C | 0.00 | 6,404 | 0 | 55,064 | 48.7 K to 55.1 K (+13.16 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 15,513 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 827,483 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 65,267 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 3,481,517 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 60,642 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 3,234,812 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 63,490 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Option Exercise | C | 0.00 | 3,386,690 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Buy | C | 0.00 | 5,940 | 0 | 5,940 | 0 to 5.9 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co ... | 10% Owner | Buy | C | 0.00 | 316,980 | 0 | 316,980 | 0 to 317 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Roberts Carmichael | 10% Owner | Option Exercise | C | 0.00 | 14,318 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Roberts Carmichael | 10% Owner | Buy | C | 0.00 | 415 | 0 | 58,414 | 58 K to 58.4 K (+0.72 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | X | 8.63 | 13,449 | 116,065 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | X | 8.63 | 10,322 | 89,079 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | X | 8.63 | 21,060 | 181,748 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,545,953 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,186,496 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 2,420,729 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,995,489 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,531,507 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 3,124,633 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 2,391,895 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,835,743 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 3,745,346 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 2,929,790 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 2,248,569 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 4,587,608 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 2,088,772 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,603,102 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 3,270,702 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,948,948 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,495,786 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 3,051,758 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,647,727 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 541,973 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,105,754 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,725,090 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 567,420 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Option Exercise | C | 0.00 | 1,157,670 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | P | 16.00 | 75,000 | 1,200,000 | 553,123 | 478.1 K to 553.1 K (+15.69 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | P | 16.00 | 57,561 | 920,976 | 381,618 | 324.1 K to 381.6 K (+17.76 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | P | 16.00 | 117,439 | 1,879,024 | 778,592 | 661.2 K to 778.6 K (+17.76 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Sell | S | 16.00 | 7,255 | 116,080 | 478,123 | 485.4 K to 478.1 K (-1.49 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | X | 8.63 | 13,449 | 116,065 | 485,378 | 471.9 K to 485.4 K (+2.85 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Sell | S | 16.00 | 5,568 | 89,088 | 324,057 | 329.6 K to 324.1 K (-1.69 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | X | 8.63 | 10,322 | 89,079 | 329,625 | 319.3 K to 329.6 K (+3.23 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Sell | S | 16.00 | 11,360 | 181,760 | 661,153 | 672.5 K to 661.2 K (-1.69 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | X | 8.63 | 21,060 | 181,748 | 672,513 | 651.5 K to 672.5 K (+3.23 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | C | 0.00 | 471,929 | 0 | 471,929 | 0 to 471.9 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | C | 0.00 | 319,303 | 0 | 319,303 | 0 to 319.3 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | ANDERSON EDWARD T | Director | Buy | C | 0.00 | 651,453 | 0 | 651,453 | 0 to 651.5 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | C | 0.00 | 23,057 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | LANGER ROBERT | Director | Buy | C | 0.00 | 668 | 0 | 15,167 | 14.5 K to 15.2 K (+4.61 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | X | 8.63 | 118 | 1,018 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | X | 8.63 | 173 | 1,493 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | X | 8.63 | 337 | 2,908 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | X | 8.63 | 17,304 | 149,334 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 13,625 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 19,890 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 38,765 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 1,988,991 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 43,966 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 64,183 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 125,094 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 6,418,387 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 52,700 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 76,934 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 149,944 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 7,693,406 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 58,980 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 86,101 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 167,809 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 8,610,081 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 22,580 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 32,961 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 64,237 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 3,296,014 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 42,941 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 62,687 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 122,177 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 6,268,687 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 16.00 | 413 | 6,608 | 7,274 | 6.9 K to 7.3 K (+6.02 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 16.00 | 603 | 9,648 | 10,618 | 10 K to 10.6 K (+6.02 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 16.00 | 1,176 | 18,816 | 20,701 | 19.5 K to 20.7 K (+6.02 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 16.00 | 60,308 | 964,928 | 1,062,259 | 1 M to 1.1 M (+6.02 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 16.00 | 64 | 1,024 | 6,861 | 6.9 K to 6.9 K (-0.92 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | X | 8.63 | 118 | 1,018 | 6,925 | 6.8 K to 6.9 K (+1.73 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 16.00 | 94 | 1,504 | 10,015 | 10.1 K to 10 K (-0.93 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | X | 8.63 | 173 | 1,493 | 10,109 | 9.9 K to 10.1 K (+1.74 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 16.00 | 182 | 2,912 | 19,525 | 19.7 K to 19.5 K (-0.92 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | X | 8.63 | 337 | 2,908 | 19,707 | 19.4 K to 19.7 K (+1.74 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 16.00 | 9,334 | 149,344 | 1,001,951 | 1 M to 1 M (-0.92 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | X | 8.63 | 17,304 | 149,334 | 1,011,285 | 994 K to 1 M (+1.74 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 6,807 | 0 | 6,807 | 0 to 6.8 K |
May 06 2020 | LYRA | Lyra Therapeutics, ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 9,936 | 0 | 9,936 | 0 to 9.9 K |